JP2002535282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002535282A5 JP2002535282A5 JP2000594481A JP2000594481A JP2002535282A5 JP 2002535282 A5 JP2002535282 A5 JP 2002535282A5 JP 2000594481 A JP2000594481 A JP 2000594481A JP 2000594481 A JP2000594481 A JP 2000594481A JP 2002535282 A5 JP2002535282 A5 JP 2002535282A5
- Authority
- JP
- Japan
- Prior art keywords
- chronic
- human
- composition
- heart disease
- circulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001684 chronic effect Effects 0.000 description 17
- 208000019622 heart disease Diseases 0.000 description 14
- 239000003814 drug Substances 0.000 description 8
- 102000052586 bactericidal permeability increasing protein Human genes 0.000 description 6
- 108010032816 bactericidal permeability increasing protein Proteins 0.000 description 6
- 102100035131 Lipopolysaccharide-binding protein Human genes 0.000 description 5
- 208000020446 Cardiac disease Diseases 0.000 description 3
- 206010007559 Cardiac failure congestive Diseases 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 208000031229 Cardiomyopathies Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000004041 inotropic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11673699P | 1999-01-22 | 1999-01-22 | |
| US60/116,736 | 1999-01-22 | ||
| PCT/US2000/001515 WO2000043028A2 (en) | 1999-01-22 | 2000-01-21 | Method of treating chronic cardiac disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007010878A Division JP2007126479A (ja) | 1999-01-22 | 2007-01-19 | 慢性心臓疾患を処置する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002535282A JP2002535282A (ja) | 2002-10-22 |
| JP2002535282A5 true JP2002535282A5 (enExample) | 2007-03-08 |
Family
ID=22368911
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000594481A Pending JP2002535282A (ja) | 1999-01-22 | 2000-01-21 | 慢性心臓疾患を処置する方法 |
| JP2007010878A Withdrawn JP2007126479A (ja) | 1999-01-22 | 2007-01-19 | 慢性心臓疾患を処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007010878A Withdrawn JP2007126479A (ja) | 1999-01-22 | 2007-01-19 | 慢性心臓疾患を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6509317B1 (enExample) |
| EP (1) | EP1143996B1 (enExample) |
| JP (2) | JP2002535282A (enExample) |
| CN (1) | CN1353614A (enExample) |
| AT (1) | ATE239492T1 (enExample) |
| AU (1) | AU778001B2 (enExample) |
| CA (1) | CA2359681A1 (enExample) |
| DE (1) | DE60002552T2 (enExample) |
| MX (1) | MXPA01007031A (enExample) |
| NZ (1) | NZ513087A (enExample) |
| WO (1) | WO2000043028A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1339424A2 (en) | 2000-12-01 | 2003-09-03 | XOMA Technology Ltd. | Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| WO2010062738A1 (en) * | 2008-11-03 | 2010-06-03 | Ut-Battelle, Llc | Diagnosis and treatment of congenital heart defects using nell 1 |
| US9974759B2 (en) * | 2013-05-31 | 2018-05-22 | Indiana University Research And Technology Corporation | Beta 2 adrenoceptor antagonists for treating orthostatic hypotension |
| GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
| GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643875A (en) | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| US5578568A (en) | 1994-04-22 | 1996-11-26 | Xoma Corporation | Method of treating conditions associated with intestinal ischemia/reperfusion |
| US5646114A (en) * | 1994-07-11 | 1997-07-08 | Xoma Corporation | Anti-protozoan methods |
| DK0914144T3 (da) * | 1996-05-10 | 2001-04-09 | Univ Texas | Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi |
-
2000
- 2000-01-21 JP JP2000594481A patent/JP2002535282A/ja active Pending
- 2000-01-21 WO PCT/US2000/001515 patent/WO2000043028A2/en not_active Ceased
- 2000-01-21 DE DE60002552T patent/DE60002552T2/de not_active Expired - Fee Related
- 2000-01-21 CA CA002359681A patent/CA2359681A1/en not_active Abandoned
- 2000-01-21 AU AU27341/00A patent/AU778001B2/en not_active Ceased
- 2000-01-21 CN CN00805115A patent/CN1353614A/zh active Pending
- 2000-01-21 MX MXPA01007031A patent/MXPA01007031A/es not_active IP Right Cessation
- 2000-01-21 EP EP00905696A patent/EP1143996B1/en not_active Expired - Lifetime
- 2000-01-21 US US09/488,979 patent/US6509317B1/en not_active Expired - Fee Related
- 2000-01-21 NZ NZ513087A patent/NZ513087A/xx unknown
- 2000-01-21 AT AT00905696T patent/ATE239492T1/de not_active IP Right Cessation
-
2003
- 2003-01-14 US US10/342,169 patent/US7045501B2/en not_active Expired - Fee Related
-
2006
- 2006-04-05 US US11/398,989 patent/US20060171937A1/en not_active Abandoned
-
2007
- 2007-01-19 JP JP2007010878A patent/JP2007126479A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004527551A5 (enExample) | ||
| Zimmerman et al. | Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia | |
| Sezai et al. | Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery | |
| JP2002542270A5 (enExample) | ||
| JP2002544238A5 (enExample) | ||
| CA2416492A1 (en) | Treatment of glycogen storage disease type ii | |
| JP2002535282A5 (enExample) | ||
| RU2002130200A (ru) | Композиции для доставки лекарственного средства | |
| AU2011249858B2 (en) | Methods and agents for enhancing wound healing | |
| US5571535A (en) | Treatment of topical infections | |
| CA2354029A1 (en) | Gene therapy for cardiomyopathy | |
| CN101325965A (zh) | 治疗粘膜破坏性炎症的转铁蛋白的应用 | |
| EE200300504A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
| JP2006503901A5 (enExample) | ||
| RU2131727C1 (ru) | Способ нормализации физиологического состояния по левину | |
| EA200501846A1 (ru) | Плазмида, кодирующая фактор роста фибробластов, для лечения ангиогенных дефектов, ассоциированных с гиперхолестеринемией или диабетом | |
| JP2011522875A (ja) | 電気的除細動を予防するためのドロネダロン | |
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| NZ513087A (en) | Bactericidal/permability -increasing protein (BPI) for treating chronic heart disease | |
| US20180110803A1 (en) | Neutral Electrolyzed Water and Uses Thereof | |
| EE200300495A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
| EE200300506A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
| JPH0219323A (ja) | 鼻粘膜保護剤の製造にリゾチームを使用する方法 | |
| KR101465843B1 (ko) | 천연 염료 치질 화장지, 연고 치질 화장지 및, 이의 제조방법 | |
| Muller et al. | Differential treatment effects of amisulpride versus flupentixol on latent dimensions of depressive and negative symptoms in acute schizophrenia |